With Three-Year Revenue Growth of 287% AI-Powered Solution Provider Ranks Among America’s Fastest-Growing Private Companies
NEW YORK, August 13, 2024 – Inc. revealed today that Intelligencia AI, a provider of AI-powered solutions that support data-driven decision-making in drug development, ranks No. 1819 on the 2024 Inc. 5000. The annual list recognizes the fastest-growing private companies in America. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment—its independent, entrepreneurial businesses.
Intelligencia AI focuses on de-risking drug development and augmenting decision-making by helping pharmaceutical companies better understand and manage risk. The combination of deep domain expertise, harmonized biological and clinical data, proprietary ontologies, and accurate AI-driven probability of technical and regulatory success (PTRS) assessments complements human intuition and judgment.
CEO and co-founder Dimitrios Skaltsas expressed, “We have reached many incredible milestones since our inception, and this is certainly one of them. Making this prestigious list shows the dedication of our entire team and the trust and support of our partners and customers. This recognition further inspires us to develop powerful AI-based tools that speed up clinical development and help pharmaceutical companies de-risk critical business decisions.”
Intelligencia AI achieved another milestone in April of this year when the company received a U.S. patent for its novel techniques in training and leveraging a machine learning (ML) model to predict the likelihood of FDA approval for a particular drug.
About Intelligencia AI
Intelligencia AI™ leads the way in leveraging proprietary data, biomedical expertise and artificial intelligence (AI) with its patented technology to address significant challenges in the pharmaceutical industry. These challenges include lengthy drug development timelines, excessive costs, and unsustainable return on investment (ROI). Its suite of AI-powered solutions delivers actionable insights crucial in mitigating risks and enhancing decision-making associated with drug development by providing an accurate, unbiased assessment of a drug’s probability of success.
Founded in 2017, Intelligencia AI is headquartered in New York, NY, with offices in Athens, Greece, and employs 110 individuals globally. Visit intelligencia.ai to discover more.
More about Inc. and the Inc. 5000
Methodology
Companies on the 2024 Inc. 5000 are ranked according to percentage revenue growth from 2020 to 2023. To qualify, companies must have been founded and generating revenue by March 31, 2020. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2023. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2020 is $100,000; the minimum for 2023 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places.
About Inc.
Inc. Business Media is the leading multimedia brand for entrepreneurs. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.’s award-winning work achieves a monthly brand footprint of more than 40 million across a variety of channels, including events, print, digital, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced every year since its launch as the Inc. 100 in 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, gives the founders of top businesses the opportunity to engage with an exclusive community of their peers, and credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com.
###